Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Operating Leases (2023 - 2025)

Historic Operating Leases for Connect Biopharma Holdings (CNTB) over the last 3 years, with Q3 2025 value amounting to $781000.0.

  • Connect Biopharma Holdings' Operating Leases changed N/A to $781000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $781000.0, marking a year-over-year change of. This contributed to the annual value of $24000.0 for FY2024, which is 8666.67% down from last year.
  • Connect Biopharma Holdings' Operating Leases amounted to $781000.0 in Q3 2025.
  • In the past 5 years, Connect Biopharma Holdings' Operating Leases registered a high of $940000.0 during Q1 2025, and its lowest value of $24000.0 during Q4 2024.
  • Over the past 3 years, Connect Biopharma Holdings' median Operating Leases value was $323000.0 (recorded in 2023), while the average stood at $481428.6.
  • Per our database at Business Quant, Connect Biopharma Holdings' Operating Leases tumbled by 8666.67% in 2024 and then soared by 24523.81% in 2025.
  • Quarter analysis of 3 years shows Connect Biopharma Holdings' Operating Leases stood at $180000.0 in 2023, then tumbled by 86.67% to $24000.0 in 2024, then skyrocketed by 3154.17% to $781000.0 in 2025.
  • Its Operating Leases stands at $781000.0 for Q3 2025, versus $870000.0 for Q2 2025 and $940000.0 for Q1 2025.